Ofloxacin and MetronidazoleThird Party Manufacturing in India

Ofloxacin and Metronidazole work synergistically to eliminate a broad spectrum of bacterial and protozoal pathogens responsible for mixed infections.

Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, abruptly halting DNA replication in aerobic Gram-positive and Gram-negative bacteria. Simultaneously, Metronidazole enters anaerobic bacteria and protozoa, where it is reduced to highly reactive intermediates that bind to and fracture the organism's DNA. This combined biological effect helps the body comprehensively clear complex, polymicrobial infections that a single agent cannot resolve.

Unlike monotherapies, the Ofloxacin and Metronidazole combination provides robust, simultaneous coverage against aerobes, anaerobes, and protozoa. It is highly effective and well-tolerated for patients with severe gastrointestinal and pelvic infections.

Therapeutic Uses

Ofloxacin and Metronidazole are prescribed for the treatment of:

• Diarrhea and Dysentery: Rapidly resolves gastrointestinal infections caused by a mix of aerobic bacteria, anaerobic bacteria, and protozoa.
• Intra-abdominal Infections: Provides essential broad-spectrum coverage for peritonitis and other complex intra-abdominal sepsis cases.
• Pelvic Inflammatory Disease (PID): Highly effective against the polymicrobial etiology of acute PID.
• Dental Infections: Used to treat severe periodontitis and mixed oral infections involving anaerobic flora.
• Gynecological Infections: Treats bacterial vaginosis and trichomoniasis efficiently.

Why Manufacturers Choose Ofloxacin and Metronidazole

The pairing of Ofloxacin and Metronidazole is recognized as an industry standard for treating mixed gastrointestinal and pelvic infections. The synergistic action of these two proven APIs offers reliable clinical outcomes, leading to sustained, high-volume prescription rates. It is particularly popular in liquid suspension formulations for pediatric use and tablet forms for adults.

This makes Ofloxacin and Metronidazole one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies targeting comprehensive infectious disease management.